Multiplex serum biomarker assessments: technical and biostatistical issues.
about
Bioanalytical chemistry of cytokines--a reviewLipopolysaccharide-Induced Profiles of Cytokine, Chemokine, and Growth Factors Produced by Human Decidual Cells Are Altered by Lactobacillus rhamnosus GR-1 Supernatant.Development and implementation of a proficiency testing program for Luminex bead-based cytokine assays.Chemokines CCL3/MIP1α, CCL5/RANTES and CCL18/PARC are independent risk predictors of short-term mortality in patients with acute coronary syndromes.Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-α but Not Observation in Intermediate Risk Melanoma Patients.Cytokines as Biomarkers of Pancreatic Ductal Adenocarcinoma: A Systematic Review.Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma.Pitfalls in retrospective analyses of biomarkers: a case study with metastatic melanoma patients.Translational pharmacokinetic-pharmacodynamic modeling from nonclinical to clinical development: a case study of anticancer drug, crizotinib.Biomarkers for Alzheimer's disease in plasma, serum and blood - conceptual and practical problemsStability of pro- and anti-inflammatory immune biomarkers for human cohort studies.Wound samples: moving towards a standardised method of collection and analysis.Psychiatric disorders biochemical pathways unraveled by human brain proteomics.Minimizing antibody cross-reactivity in multiplex detection of biomarkers in paper-based point-of-care assays.Immune responses to cancer: are they potential biomarkers of prognosis?Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy.Effects of freezer storage time on levels of complement biomarkers.
P2860
Q26851317-5472C3F7-05FF-434B-A58E-0486B417131EQ33936684-CA60459B-7352-4992-8D98-08794843D145Q34066926-C7B46FF6-0385-454C-8532-43F0BE2EDA1FQ34430115-A820F844-C485-4331-AEBC-350257262FA7Q35698637-8F53CB77-7EE3-401C-B9AF-20002F86F104Q36015280-C5E3B8C0-F024-4EE1-8FA3-388FE75DF1F2Q36061606-CFFC9B81-401E-47D8-AD87-00179E1AE350Q36320424-8F071DCF-F73B-4FB9-AE2F-0079179AC7C8Q36910546-15F2761B-7431-48CD-94C3-AABE2F8081AFQ36997922-6A4B9DA7-E0A7-4CB4-B48A-5CD19A5608C1Q37679161-85623FB5-DDC3-42A1-B587-833A4926D10BQ38315546-EBF9BF22-2E73-457F-916B-6723999E02CEQ38885740-FC2CC18A-73F9-4B6A-8B1B-B53A51EEE119Q39876098-B6DE23CB-C9EE-4868-BDDC-28A1D59ED637Q40778413-C9E65C8A-F296-4033-9A35-F013443C5AE3Q46822230-F0EA8501-B0D9-406B-BD6D-59516F78C569Q47110053-D040590D-5EE8-4365-A551-DEDB0C19E55A
P2860
Multiplex serum biomarker assessments: technical and biostatistical issues.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Multiplex serum biomarker assessments: technical and biostatistical issues.
@en
type
label
Multiplex serum biomarker assessments: technical and biostatistical issues.
@en
prefLabel
Multiplex serum biomarker assessments: technical and biostatistical issues.
@en
P2860
P356
P1476
Multiplex serum biomarker assessments: technical and biostatistical issues.
@en
P2093
Douglas M Potter
John M Kirkwood
P2860
P2888
P356
10.1186/1479-5876-9-173
P577
2011-10-11T00:00:00Z
P5875
P6179
1018149223